Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by MÄKI-IKOLA, O.
Right arrow Articles by GRANFORS, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MÄKI-IKOLA, O.
Right arrow Articles by GRANFORS, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1994 British Society for Rheumatology

research-article

IgM, IgA AND IgG CLASS SERUM ANTIBODIES AGAINST KLEBSIELLA PNEUMONIAE AND ESCHERICHIA COLI LIPOPOLYSACCHARIDES IN PATIENTS WITH ANKYLOSING SPONDYLITIS

O. MÄKI-IKOLA*, K. LEHTINEN{dagger}, M. NISSILÄA{dagger} and K. GRANFORS*,

*National Public Health Institute Turku
{dagger}Rheumatism Foundation Hospital Heinola, Finland

Correspondence to: K. Granfors, National Public Health Institute, Department in Turku, Kiinamyllnkatu 13, SF-205201 Turku, Finland.

IgM, IgA and IgG class serum antibodies against Klebsiella pneumoniae and Escherichia coli lipopolysaccharides (LPS) were studied by ELISA in two separate AS patient populations of 99 and 81 subjects and in 102 healthy blood donors. In the first patient population increased levels of IgM and IgG class antibodies against K. pneumoniae LPS were observed in patients with active AS. In the population with active AS, increased levels of IgM, IgA and IgG class antibodies against K. pneumoniae LPS and IgA class antibodies against E. coli LPS were observed. Sulphasalazine treatment decreased IgM and IgA class antibody levels significantly against K. pneumoniae LPS and IgM class antibodies against E. coli LPS. These findings suggest that a significant part of the aati-Klebsiella antibodies found in AS patients is directed against the LPS component of Klebsiella.

KEY WORDS: Ankylosing spondylitis, Antibodies, Klebsiella, Escherichia coli, ELISA, Lipopolysaccharide


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann Rheum DisHome page
O MÄKI-IKOLA, J MERTSOLA, K GRANFORS, P KUUSELA, K LEHTINEN, R VON ESSEN, and H SAXEN
No endotoxin detected in plasma of patients with ankylosing spondylitis
Ann Rheum Dis, April 1, 1997; 56(4): 279 - 279.
[Full Text]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.